European Stocks Rise Amid Growth Optimism, Health-Care Gains
- ABN Amro rises on first day of Amsterdam trading after IPO
- Barclays leads banks lower as Morgan Stanley cuts rating
This article is for subscribers only.
European stocks rose for a second day, extending a three-month high, amid investor optimism about global growth, while gains in health-care companies helped offset declines in banks.
AstraZeneca Plc led drugmakers higher with a 1.6 percent advance. ABN Amro Group NV climbed 3.4 percent on its first day of trading in Amsterdam after an initial public offering. Glencore Plc fell 1.8 percent as miners erased earlier gains. Barclays Plc led lenders lower, falling 3.5 percent after Morgan Stanley cut its rating to equal weight, citing risks to consensus earnings estimates.